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A Novel Antimicrobial Peptide on the Ocular Surface
Shows Decreased Expression in Inflammation
and Infection
Asiya Abedin,1,2 Imran Mohammed,1,2 Andrew Hopkinson,1 and Harminder S. Dua1
PURPOSE. Antimicrobial peptides (AMPs) are cationic host defense
peptides with microbicidal and cell-signaling properties. They
show promise as potential therapeutic agents. In the present
study, a !-defensin AMP gene was isolated from the ocular surface
for the first time, and its expression was characterized in the
presence of ocular inflammation and/or infection.
METHODS. Total RNA was obtained from impression cytology
samples of the conjunctiva and cornea of normal patients and
of those with bacterial, viral, acanthamoeba, or dry eye disease.
The expression of the !-defensin AMP DEFB-109 was deter-
mined by using reverse transcription-polymerase chain reac-
tion (RT-PCR). Relative quantification of the gene in the various
groups was performed by means of real-time PCR.
RESULTS. DEFB-109 was constitutively expressed in all samples.
The gene showed significantly decreased expression in the
presence of all types of inflammation/infection. Reduced ex-
pression featured most prominently in acanthamoeba infec-
tion; the least change from normal was in dry eye.
CONCLUSIONS. The discovery of DEFB-109 on the ocular surface
enhances our knowledge of the profile of AMPs at this impor-
tant mucosal surface. The fact that its expression is signifi-
cantly reduced in both inflammatory and infective ocular sur-
face disease reflects not only an intimate balance between this
host defense gene and microbes but indicates a role other than
purely microbicidal. This discovery will enable the mecha-
nisms behind the intriguing phenomenon of reduced gene
expression of an AMP in disease states to be uncovered. (Invest
Ophthalmol Vis Sci. 2008;49:28–33) DOI:10.1167/iovs.07-0645
The importance of vision in the survival of a species and theexposed location of the eyes is the likely reason for a very
full repertoire of antimicrobial activities at the ocular surface.
Antimicrobial peptides (AMPs) feature prominently among
these. AMPs are small cationic polypeptides found in plants,
invertebrates, and vertebrates. They exhibit microbicidal prop-
erties against bacteria,1,2 fungi, mycobacteria,3 yeasts,4 and
enveloped viruses.2 AMPs are effectors of innate immunity5
found in mammalian neutrophils and various epithelia. They
also bridge innate and adaptive immunity by participating in
cell signaling6 and acting as chemoattractants for immature
dendritic and T cells.7 They have a multitude of functions on
the ocular surface, as elsewhere. Wound healing and protec-
tion from infection appear to be important functions of some
AMPs, such as LL-37 , and the eye is a particular case in point.8
The AMPs even have retinal trophic and antiangiogenic prop-
erties potentially making them attractive agents for treatment
of macular degeneration.9 Increased AMP production in human
tears has been found to be protective after ocular surface
surgery,10 and within the eye AMPs suppress endotoxin-in-
duced uveitis.11 Sometimes their presence is undesirable as
when upregulation of HBD2 is associated with the ocular
irritation of non-Sjo¨gren’s dry eye.12 They belong to one of
three groups, "-, !-, and #-defensins, but only the first two have
been isolated in humans.13 Human !-defensin 1 (HBD1) is
known to be constitutively expressed,14,15 whereas HBD2 is
inducible by inflammation.16 Both these and other AMPs have
been found to be expressed at various sites7,8 in addition to the
eye.17–20 They have been found to increase the antimicrobial
property of contact lens cleaning solutions21 as well as that of
corneal storage media.22 Topical application of AMPs is con-
sidered to have considerable therapeutic potential.23–26
Therein lies the importance of any new AMP found to be
expressed on the ocular surface; the hidden Markov model of
the human genome and EST libraries together identify 28 novel
!-defensin-like genes. However, the AMP DEFB-109 has not
been reported in ocular cells. We report for the first time the
constitutive expression of DEFB-109 in ocular surface cells
obtained by impression cytology. Furthermore, we note a sig-
nificantly reduced expression of DEFB-109 in impression cy-
tology specimens obtained from the ocular surface in the
presence of infection and dry eye. This reduced expression
was demonstrated by real-time PCR (quantitative PCR [QPCR])
of the DEFB-109 gene in bacterial, viral, and acanthamoeba
ocular infection as well as dry eye.
METHODS
The research was approved by the local ethics committee and the
Research and Development Department of the National Health Service
Trust. All research was conducted in accordance with the tenets of the
Declaration of Helsinki.
Sample Collection
Informed consent was obtained before sample collection. Ocular sur-
face cells were collected from normal eyes of patients coming for
evaluation before cataract surgery (n ! 3) and from persons with
bacterial infection (n! 3), viral infection (n! 3), Acanthamoeba spp.
keratitis (n ! 3) and dry eye disease (n ! 3). Corneal and conjunctival
cells were collected by impression cytology. Hydrophilic 13-mm filter
paper discs of mixed cellulose esters and pore size 0.45 $m (Millipore
Corp., Bedford, MA) were used. A hemidisc of filter paper was applied
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to the ocular surface of interest with a fine nontoothed forceps after
the eye was adequately anesthetized with amethocaine (0.5%) or
benoxinate (0.4%) drops. Then, the membrane was “peeled” off and
stored (Buffer RLT; RNeasy Minikit; Qiagen, Crawley, UK) at "80°C.
To ensure maximum cell recovery, each area was sampled twice.
Testis
PCR-ready human testicular cDNA (0.5 ng/$L; Ambion, Huntingdon,
UK) was used as a control template for the PCR and QPCR experi-
ments.
Placenta Collection
Fetal membranes were procured from consenting patients undergoing
elective caesarean section near term and delivering healthy infants and
were processed according to established procedures in our labora-
tory.27 Fresh placental samples were collected and RNA extracted.
These were used as the control for conventional PCR.
Peripheral Blood Monocytes
Peripheral blood monocytes were isolated by established methods.28
These were also used as the control for conventional PCR.
Isolation of RNA and cDNA Synthesis
Total RNA was extracted from the corneal and conjunctival impression
cytology samples, as well as placenta and PBMCs using a commercial
kit (RNeasy Minikit and Qiashredder columns; Qiagen) according to
the manufacturer’s instructions. Ethanol precipitation of RNA from
several pooled samples from each category was performed for those
samples in which the RNA concentration was below 44 ng/$L, as
described by Weichenhan (http://www.science.ngfn.de.index-455.htm).
Reverse transcription of all RNA samples to first-strand cDNA was
performed (SuperScript III Reverse Transcriptase; Invitrogen, Paisley,
UK) according to the manufacturer’s protocol (but replacing
RNaseOUT with SuperaseIn; Ambion) and using random hexamer
primers (Promega, Southampton, UK).
Polymerase Chain Reaction
Primer sequences for each gene (Table 1) were designed based on
sequences retrieved online from the Universal Probe Library (www.
probelibrary.com, Roche Diagnostics, Basel, Switzerland) and ordered
through MWG-Biotech (Covent Garden, London, UK). Each reaction
was prepared with a commercial buffer (final concentrations: 60 mM
Tris/HCl [pH 8.5], 15 mM (NH4)2 SO4 and 2 mM MgCl2; [Invitrogen]),
dNTPs (0.25 mM final concentration; Invitrogen), 0.01% (vol/vol)
Tween 20 (Sigma-Aldrich, Dorset, UK), 500 $M of each primer (MWG-
Biotech), 0.5 U Taq DNA polymerase (Amplitaq Gold; Applied Biosys-
tems Inc., Warrington, UK), and 0.5 $L first-strand cDNA, in a total
volume of 25 $L. Reactions underwent an initial cycle at 95°C for 15
minutes followed by 37 cycles of 94°C for 30 seconds, 58°C for 1
minute 30 seconds, 72°C for 2 minutes, and a final incubation at 72°C
for 20 minutes. cDNA quality was assessed by PCR with primers
targeted to hypoxanthine guanine phosphoribosyltransferase (HPRT,
GenBank accession no. NM_000194; MWG-Biotech).
Gel Electrophoresis Analysis
The products of each PCR were analyzed on ethidium-bromide–stained
1% (wt/vol) agarose gels. All samples were positive for HPRT primers
and were analyzed further by QPCR.
Sequencing of Gene of Interest
We sequenced the DNA bands appearing on the gels to confirm the
product of interest (Fig. 1). An impression cytology sample from a
normal individual was run in duplicate, and the two DNA fragments
obtained were excised from the agarose gel and pooled, and the
manufacturer’s (QIAquick Gel Extraction Kit; Qiagen) protocol was
used for elution of the DNA. The sample was then air-dried and sent for
sequencing (MWG-Biotech) using the reverse primer for DEFB-109 .
Real-Time QPCR
Real-time QPCR analysis was performed using DEFB-109 and HPRT
primers (MWG Biotech) to allow calculation of the relative abundance
of transcripts.
Reactions were prepared with 12.5 $L 2# PCR master mix (Bril-
liant SYBR Green QPCR Master Mix; Stratagene, Amsterdam, The Neth-
erlands), 500 $M final concentration of each primer, 0.75 $L reference
dye (Stratagene), and 5 $L of each cDNA (10 ng/$L) in a final volume
of 25 $L. HPRT was used as the reference gene. All reactions were run
in a real-time PCR system (Mx3005P; Stratagene). A standard curve was
TABLE 1. Details of the Housekeeping and DEFB-109 Genes and Their Primers
Genes
Accession
Number Primer Primer Sequence
Amplicon
Size (bp)
HPRT NM_000194 F 5$-tgatagatccattcctatgactgtaga-3$ 126
R 5$-aagacattctttccagttaaagttgag-3$
DEFB-109 NM_001037380 F 5$-cccagtaagaggtggtttgg-3$ 106
R 5$-gcaggcaccaatttgatctt-3$
F IGURE 1. Sequence of DEFB-109
gene confirmed by gel extraction and
purification from one of our samples
(normal conjunctival impression cy-
tology sample). The underlined se-
quence within the gene is the se-
quence of interest.
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generated by fivefold serial dilutions of human reference total RNA
(Stratagene), concentrations of which were adjusted to allow the
values of “unknown” samples to fall between their extremes. Experi-
ments were optimized such that PCR efficiencies for the reactions fell
between 90% and 110% and the standard curve slope was between
"3.1 and "3.5. Target and endogenous reference gene PCR efficien-
cies obtained were similar (Figs. 2, 3). Primer concentrations and
annealing temperature were optimized to eliminate any confounding
primer-dimers. Each standard curve was obtained by running the ex-
periment in triplicate, and control and unknown samples were run in
duplicate. Results are representative of three such experiments. Each
plate was run at 95°C for 15 minutes, then 45 cycles of 95°C for 30
seconds, 58°C for 30 seconds, and 72°C for 30 seconds, followed by
dissociation at 95°C for 1 minute, 58°C for 30 seconds, and 95°C for 30
seconds.
Statistical Analysis of Real-Time PCR Data and
Relative Quantitation of Gene Expression
The standard curve method29 was used to calculate relative quantities
of gene expression in the different disease groups compared with the
control group, using HPRT as the endogenous reference gene. Similar
PCR efficiencies for the DEFB-109 and HPRT genes enabled relative
quantitation of transcripts by the Pfaffl method,30 so that the normal-
ized DEFB-109 gene expression in each of the samples was calculated
by the formula 2"%%CT. A greater normalized CT indicated a higher
level of gene expression. Commercial software (Prism, ver. 4.00 for
Windows; GraphPad Software, San Diego, CA) was used to analyze the
data. The Kruskal-Wallis nonparametric statistical analysis test was
applied assuming a non-Gaussian distribution of data.
RESULTS
RT-PCR Analysis of Expression of DEFB-109
RT-PCR showed the expression of DEFB-109 to be constitu-
tive; 1% agarose gel electrophoresis was positive for the gene
in all tissues. Placental tissue showed a comparatively low level
of gene expression. Impression cytology samples from all dis-
ease groups showed clear expression of DEFB-109 , as did the
control samples (Fig. 4).
Real-Time Quantitative PCR Analysis of
Expression of DEFB-109
We ran three experiments for each of the groups of normal,
bacterial, viral, dry eye, and acanthamoeba specimens. Each of
the three real-time PCR experiments were run in duplicate
with appropriate fivefold serially diluted standards obtained
from human reference total RNA (Stratagene). All samples
showed expression of the gene of interest in a constitutive
manner, and quantitative values of expression were obtained
(Table 2). Significantly reduced expression of DEFB-109 was
noted in samples obtained from all four patient groups com-
pared with normal samples. The reduction in quantitative ex-
pression of the DEFB-109 gene was in the following order: dry
F IGURE 2. The amplification curve, dissociation curve, and standard curve obtained for HPRT in real-time PCR experiments.
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eye, bacterial and viral infections, and acanthamoeba infec-
tions, with dry eye showing the least and acanthamoeba the
most reduction. Testis specimens (positive control) showed
high expression of this defensin (data not shown).
The downregulation of DEFB-109 in all disease groups was
significant (P! 0.0399, or P% 0.05). Average gene expression
levels in each group were also reduced in diseased compared
with normal specimens (Fig. 5).
DISCUSSION
The conjunctiva and cornea are ideally positioned as the first
line of defense in the eye, and it is for this reason that the
repertoire of !-defensins expressed therein warrants thorough
study, to understand conclusively the role of these surfaces in
innate and acquired immunity. Our discovery of DEFB-109 on
the ocular surface expands current knowledge of the reper-
toire of ocular surface AMPs. The promise of AMPs as thera-
peutic agents, either alone or as adjuvants to host modulatory
factors and standard antimicrobial therapies, further under-
scores the importance of understanding the full complement of
AMPs at this important mucosal surface. The physiological
significance of newer AMPs and the nonmicrobicidal functions
of all AMPs must be understood before this potential can be
realized.
There are approximately 900 AMPs known to exist at vari-
ous sites. We have already shown expression of a number of
AMPs on the ocular surface.20 "-Defensin-1 to -3 were demon-
strated in neutrophils of inflamed conjunctiva and HBD1 and -2
in ocular surface epithelium.17,18 In contrast to most epithelial
sites where HBD1 is constitutively expressed and HBD2 is
inducible, at the ocular surface both these defensins are con-
stitutively expressed.17,18,20 Other AMPs of note demonstrated
at the ocular surface include HBD3, liver-expressed AMPs 1
and 2 (LEAP1, -2) and cathelicidin (LL37 ).20 In our earlier
TABLE 2. Relative Quantitative Expression of DEFB-109 in the
Disease Groups as Compared to Normal Eyes
Samples
(n ! 3)
Average
Relative Gene
Expression
(2"##CT) SD Range
Control 1 0 0.7–1.5
Bacterial 0.24 0.096 0.14–0.25
Viral 0.23 0.023 0.21–0.25
Acanthamoeba 0.04 0.02 0.02–0.06
Dry Eye 0.30 0.065 0.24–0.37
F IGURE 3. The amplification curve, dissociation curve, and standard curve obtained for DEFB-109 in real-time experiments.
F IGURE 4. Agarose gel (1%) electrophoresis after RT-PCR to illustrate
the constitutive nature of DEFB-109 expression in a variety of tissue.
The first five lanes from the left are impression cytology samples.
Control signifies an impression cytology sample from a normal eye.
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study, we noted that the highest normalized expression levels
by means of real-time PCR were for HBD1, -2, and -3 and
LEAP2.20
Beta defensins have been demonstrated to have good activ-
ity against most bacteria and excellent activity against highly
resistant bacteria, such as Pseudomonas aeruginosa and me-
thicillin-resistant Staphylococcus aureus, with a minimum in-
hibitory concentration (MIC) of 1 to 4 $g/mL against the latter
group.30
It is likely that more AMPs and their roles remain to be
discovered and elucidated. Primers designed on the basis of the
hidden Markov model and expressed sequence tag (EST) librar-
ies have been used to identify numerous AMPs in the human
testis, namely HBD3, -4 , LEAP1, LEAP2, and LL37 , and 8 of 13
putative !-defensins. However, these primers did not detect
DEFB-105 , -107 , -108 , -118 to -121, -123, -125 , -127 , or -129 in
the ocular epithelium,20 supporting the notion that not all
AMPs are expressed at all sites.
We collected cells from the conjunctival and corneal sur-
faces of normal persons presenting for preoperative evaluation
before cataract extraction and also from patients with bacte-
rial, viral, acanthamoeba infection, and dry eye, by means of
impression cytology. Impression cytology is an established
noninvasive technique of conjunctival biopsy31,32 which we
have modified to improve efficacy.33 We are able to harvest the
top two or three layers of ocular surface cells by this method.
Each area was sampled twice to ensure an adequate sheet of
cells. We used human testis cells, human placenta, and PBMC
as control samples. Conventional PCR using cDNA reverse-
transcribed from the RNA of the above samples showed con-
stitutive expression of DEFB-109 in all the tissues taken. The
level of expression in placenta was less than in the other
samples (Fig. 4). Quantitative real-time PCR34 was subse-
quently run for these samples. Premratanachai et al.35 have
investigated the expression and regulation of novel !-defensins
DEFB-104 to -114 in gingival keratinocytes. They reported the
constitutive expression of DEFB-109 and its downregulation
after stimulation with Candida albicans. However, their work
was on cultured gingival keratinocytes rather than on cell
samples, as in our study. Though others36 have detected down-
regulation of LL37 in lower gut infection, our previous work
failed to detect any such trend in ocular infections.20 Hence,
the profile and behavior of AMPs of the ocular surface are
distinct and unique to this site.
The expression of DEFB-109 was seen to be constitutive.
This is in keeping with its close relationship with HBD1 in
phylogenetic terms, as deduced by Kao et al.37 based on their
genome-wide search of the hidden Markov model profile
against the ORFeome peptide database (available in the public
domain at www.orfeomecollaboration.org) for this and other
novel DEFB genes. Of interest, DEFB-109 showed reduced
expression in each of the infected patient categories. The
downregulation of the gene seen by Premratanachai et al.35 in
their patients with Candida infection was proposed to be an
escape strategy encouraging commensalism of the organism.26
As alluded to earlier, this phenomenon has also been seen with
HBD1 and LL-37 in human shigellosis. In this instance, it was
suggested to be a bacterial virulence factor.36 Also, HBD2 has
been found to be decreased in human burn wounds, which
may be related to the elevation of one or more of the proin-
flammatory cytokines IL-1, IL-6 , INF-&, and TNF-" in these
patients.38
It appears that infection and inflammation are associated
with reduced expression of DEFB-109 . Whether the reduced
expression is a cause or effect of the infection is unclear. It
remains to be seen what relationship, if any, exists between
this defensin and the cytokines, which are known to be a part
of the intracellular signaling cascade. At the moment there are
many possibilities. Further investigation into these interactions
will be necessary as more novel peptides are discovered by the
aforementioned and other computational strategies.
This is the first report of expression of the novel AMP
DEFB-109 on the ocular surface. It may play a role in wound
healing, similar to some of the other AMPs referred to herein,
and is unlikely to have a major antimicrobial effect, as it is
reduced in microbial infection. Further investigation into pro-
tein expression and signaling pathways will shed light on its
definite role. Nonetheless, the unequivocal downregulation of
this gene in inflammation (dry eye) and even more so in
infection may have important implications in understanding
the link between these peptides and myriad other aspects of
inflammation. On the other hand, it may represent an intrigu-
ing mechanism of immunoevasion by microbes, as Bishop and
Finlay39 argue that AMPs can trigger pathogen virulence. If that
is the case, strategies to reverse such evasion must be discov-
ered.
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